Scott Wise
Scott Wise publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments and Immune cells in cancer.
- World rank
- #578,772 of 7,710,434 ranked researchers
- Rank in United States
- #199,231 of 1,627,098
- Works
- 135
- Citations
- 2.6k
- Citations per work
- 19.2
What does Scott Wise research?
Scott Wise's work is mostly in Medicine (29%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5943.7%
- Health Sciences3929.2%
- Medicine3929.2%
- Life Sciences3727.1%
- 1Oncology16% of their works
- 2Molecular Biology12% of their works
- 3Immunology9% of their works
- 4Hematology8% of their works
- 5Radiology, Nuclear Medicine and Imaging6% of their works
- 6Biotechnology6% of their works
Research topics
Which keywords describe Scott Wise's research?
The keywords of their largest research topics: Immunotherapy, Tumor Microenvironment, Tumor Targeting, Tumor Regression, Immune Checkpoint Blockade, PD-1 and PD-L1, Arginine Deprivation and Bacterial Therapy.
- Genomic Aberrations
- Warburg Effect
- Chimeric Antigen Receptor
- Photothermal Therapy
- Imatinib
- Macrophage
- Bacterial Therapy
- PD-1 and PD-L1
- Tumor Regression
- Tumor Microenvironment
- Immunotherapy
- Tumor Targeting
- Immune Checkpoint Blockade
- Arginine Deprivation
- Activation
- BCR-ABL
- Nanoparticles
- CAR T Cells
- HIF-1
- Chronic Lymphocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Immunotherapy383 topics
- Tumor Microenvironment302 topics
- Tumor Targeting292 topics
- Tumor Regression282 topics
- Immune Checkpoint Blockade211 topic
- PD-1 and PD-L1211 topic
- Arginine Deprivation191 topic
- Bacterial Therapy191 topic
- Activation141 topic
- Macrophage141 topic
- BCR-ABL131 topic
- Imatinib131 topic
- Nanoparticles101 topic
- Photothermal Therapy101 topic
- CAR T Cells91 topic
- Chimeric Antigen Receptor91 topic
- HIF-191 topic
- Warburg Effect91 topic
- Chronic Lymphocytic Leukemia81 topic
- Genomic Aberrations81 topic
Where does Scott Wise work?
Scott Wise's main affiliation in the publication record is Deciphera Pharmaceuticals (United States), United States.
How many publications and citations does Scott Wise have?
OpenAlex counts 135 works and 2,594 citations for Scott Wise, an h-index of 22, ranking #578,772 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Scott Wise. Posts are plain text and can be reported.